Cargando…

Health-related quality of life in long-term head and neck cancer survivors: a comparison with general population norms

To examine the health-related quality of life (HRQL) in long-term head and neck (H&N) cancer survivors compared with general population norms. HRQL was assessed with three standardized questionnaires: the SF-36 Health Survey (Short Form 36) and the EORTC QLQ-C30 and QLQ-H&N35 (European Organ...

Descripción completa

Detalles Bibliográficos
Autores principales: Hammerlid, E, Taft, C
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2001
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363699/
https://www.ncbi.nlm.nih.gov/pubmed/11161369
http://dx.doi.org/10.1054/bjoc.2000.1576
_version_ 1782153769746694144
author Hammerlid, E
Taft, C
author_facet Hammerlid, E
Taft, C
author_sort Hammerlid, E
collection PubMed
description To examine the health-related quality of life (HRQL) in long-term head and neck (H&N) cancer survivors compared with general population norms. HRQL was assessed with three standardized questionnaires: the SF-36 Health Survey (Short Form 36) and the EORTC QLQ-C30 and QLQ-H&N35 (European Organization for Research and Treatment of Cancer Quality of Life Questionnaire, -Core 30 and -Head and Neck 35 cancer module). Altogether 135 H&N cancer patients (mean age 62 years, 31% females) of 151 survivors (89% acceptance) from a longitudinal HRQL study (n = 232) were included 3 years after diagnosis. The H&N cancer patients' SF-36 scores did not differ significantly from those of an age- and sex-matched sample (n = 871) from the Swedish normative population, except on the role-physical functioning scale. On the other hand, treatment-related side-effects and disease-specific problems (e.g., swallowing, local pain and dry mouth) measured by the H&N cancer module were, with few exceptions, significantly worse than norm values. Gender comparisons revealed that female H&N cancer patients generally scored better than the norms on both the SF-36 and the EORTC QLQ-C30, while the male patients scored significantly worse on most SF-36 scales. Patients ≥65 years more often scored worse than the norm than did patients <65. Clinically relevant differences were found on the majority of SF-36 scales in comparison of tumour sites, however, comparisons of patients with small (stage I+II) versus advanced (stage III+IV) tumours revealed few differences. Three years after diagnosis H&N cancer patients still suffer significant functional limitations/problems related to their disease and its treatment but these problems do not generally affect their overall HRQL. Tumour stage no longer differentiates HRQL at 3 years, however, factors related to the patients' age, gender and location of the tumour appear to have bearing on their reported health status. © 2001 Cancer Research Campaign http://www.bjcancer.com
format Text
id pubmed-2363699
institution National Center for Biotechnology Information
language English
publishDate 2001
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-23636992009-09-10 Health-related quality of life in long-term head and neck cancer survivors: a comparison with general population norms Hammerlid, E Taft, C Br J Cancer Regular Article To examine the health-related quality of life (HRQL) in long-term head and neck (H&N) cancer survivors compared with general population norms. HRQL was assessed with three standardized questionnaires: the SF-36 Health Survey (Short Form 36) and the EORTC QLQ-C30 and QLQ-H&N35 (European Organization for Research and Treatment of Cancer Quality of Life Questionnaire, -Core 30 and -Head and Neck 35 cancer module). Altogether 135 H&N cancer patients (mean age 62 years, 31% females) of 151 survivors (89% acceptance) from a longitudinal HRQL study (n = 232) were included 3 years after diagnosis. The H&N cancer patients' SF-36 scores did not differ significantly from those of an age- and sex-matched sample (n = 871) from the Swedish normative population, except on the role-physical functioning scale. On the other hand, treatment-related side-effects and disease-specific problems (e.g., swallowing, local pain and dry mouth) measured by the H&N cancer module were, with few exceptions, significantly worse than norm values. Gender comparisons revealed that female H&N cancer patients generally scored better than the norms on both the SF-36 and the EORTC QLQ-C30, while the male patients scored significantly worse on most SF-36 scales. Patients ≥65 years more often scored worse than the norm than did patients <65. Clinically relevant differences were found on the majority of SF-36 scales in comparison of tumour sites, however, comparisons of patients with small (stage I+II) versus advanced (stage III+IV) tumours revealed few differences. Three years after diagnosis H&N cancer patients still suffer significant functional limitations/problems related to their disease and its treatment but these problems do not generally affect their overall HRQL. Tumour stage no longer differentiates HRQL at 3 years, however, factors related to the patients' age, gender and location of the tumour appear to have bearing on their reported health status. © 2001 Cancer Research Campaign http://www.bjcancer.com Nature Publishing Group 2001-01 /pmc/articles/PMC2363699/ /pubmed/11161369 http://dx.doi.org/10.1054/bjoc.2000.1576 Text en Copyright © 2001 Cancer Research Campaign https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Regular Article
Hammerlid, E
Taft, C
Health-related quality of life in long-term head and neck cancer survivors: a comparison with general population norms
title Health-related quality of life in long-term head and neck cancer survivors: a comparison with general population norms
title_full Health-related quality of life in long-term head and neck cancer survivors: a comparison with general population norms
title_fullStr Health-related quality of life in long-term head and neck cancer survivors: a comparison with general population norms
title_full_unstemmed Health-related quality of life in long-term head and neck cancer survivors: a comparison with general population norms
title_short Health-related quality of life in long-term head and neck cancer survivors: a comparison with general population norms
title_sort health-related quality of life in long-term head and neck cancer survivors: a comparison with general population norms
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363699/
https://www.ncbi.nlm.nih.gov/pubmed/11161369
http://dx.doi.org/10.1054/bjoc.2000.1576
work_keys_str_mv AT hammerlide healthrelatedqualityoflifeinlongtermheadandneckcancersurvivorsacomparisonwithgeneralpopulationnorms
AT taftc healthrelatedqualityoflifeinlongtermheadandneckcancersurvivorsacomparisonwithgeneralpopulationnorms